Dev Karan, PhD

Publications

• Circulatory MIC-1 as a Determinant of Prostate Cancer Racial Disparity.

  (Karan D, Wick J, Dubey S, Tawfik O, Van Veldhuizen P.) Cancers (Basel). 2020 Oct 18;12(10) PMID: 33081054 PMCID: PMC7603134 10/22/2020

• The Marine Natural Product Manzamine A Inhibits Cervical Cancer by Targeting the SIX1 Protein.

  (Karan D, Dubey S, Pirisi L, Nagel A, Pina I, Choo YM, Hamann MT.) J Nat Prod. 2020 02 28;83(2):286-295 PMID: 32022559 PMCID: PMC7161578 SCOPUS ID: 2-s2.0-85079554428 02/06/2020

• Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.

  (Karan D.) Front Immunol. 2018;9:3028 PMID: 30631327 PMCID: PMC6315184 SCOPUS ID: 2-s2.0-85059829126 01/12/2019

• Withaferin A Associated Differential Regulation of Inflammatory Cytokines.

  (Dubey S, Yoon H, Cohen MS, Nagarkatti P, Nagarkatti M, Karan D.) Front Immunol. 2018;9:195 PMID: 29479354 PMCID: PMC5811468 02/27/2018

• Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice.

  (Karan D.) Vaccine. 2017 10 13;35(43):5794-5798 PMID: 28939158 PMCID: PMC5617798 SCOPUS ID: 2-s2.0-85029555973 09/25/2017

• Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer.

  (Karan D, Tawfik O, Dubey S.) Sci Rep. 2017 06 29;7(1):4378 PMID: 28663562 PMCID: PMC5491527 SCOPUS ID: 2-s2.0-85021638100 07/01/2017

• From Inflammation to Prostate Cancer: The Role of Inflammasomes.

  (Karan D, Dubey S.) Adv Urol. 2016;2016:3140372 PMID: 27429614 PMCID: PMC4939357 07/19/2016

• Prostate immunotherapy: should all guns be aimed at the prostate-specific antigen?

  (Karan D.) Immunotherapy. 2013 Sep;5(9):907-10 PMID: 23998723 PMCID: PMC5242386 SCOPUS ID: 2-s2.0-84883564686 09/04/2013

• Combination immunotherapy with prostate GVAX and ipilimumab: safety and toxicity.

  (Karan D, Van Veldhuizen P.) Immunotherapy. 2012 Jun;4(6):577-80 PMID: 22788125 07/14/2012

• Prostate cancer immunotherapy

  (Karan D, Van Veldhuizen P.) Current Cancer Therapy Reviews. 2012;8(4):237 SCOPUS ID: 2-s2.0-84874896434 12/01/2012

• Adenovirus-based immunotherapy for prostate cancer

  (Dubey S, Van Veldhuizen P, Karan D.) Current Cancer Therapy Reviews. 2012;8(4):264-270 SCOPUS ID: 2-s2.0-84874854857 12/01/2012

• Prostate cancer immunotherapy: An evolving field

  (Hashmi M, Karan D, Phadke S, Saunthararajah Y, Kambhampati S, Van Veldhuizen P.) Current Cancer Therapy Reviews. 2012;8(4):274-282 SCOPUS ID: 2-s2.0-84874842943 12/01/2012